Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Gilead's Descovy receives positive CHMP opinion for HIV infection

Feb. 29, 2016

ViiV Healthcare completes acquisition of Bristol-Myers Squibb HIV R&D portfolio

Feb. 24, 2016

Vaginal ring containing dapivirine reduces the risk of HIV-1 infection among African women

Feb. 24, 2016

FDA issues complete response letter for Remune BLA

Feb. 15, 2016

ViiV Healthcare patent describes anti-HIV compounds

Feb. 9, 2016

ViiV Healthcare patents compounds to treat HIV infection

Feb. 8, 2016

Cue collaborates with Janssen on quantitative HIV viral load test

Feb. 8, 2016

ViiV Healthcare and Janssen to collaborate to develop rilpivirine and cabotegravir regimen

Jan. 11, 2016

NIAID reports results from phase I trial of VRC-01 in people with HIV infection

Jan. 7, 2016

City of Hope discloses SENP inhibitors that prevent HIV genome integration

Dec. 30, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...